Investigation of the effects of thymoquinone on erythrocyte deformability in sepsis treatment which created by cecal perforation in rat
Authors:
- H BostanciHBH Bostanci
- K DikmenKDK Dikmen
- F M ComuFCF M Comu
- M ArslanMAM Arslan
- A KucukAKA Kucuk
Open Access
- 1 March 2018
- journal article
- research article
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 119 (3) , 152-155
Abstract
Aim: We aimed to study the effects of thymoquinone on erythrocyte deformability in an experimental model of sepsis given before or after the initiation of the sepsis model. Method: The animals were grouped as (n = 6) control, nigella sativa, sepsis, sepsis group with administration of nigella sativa before sepsis development and sepsis group with nigella sativa administration after sepsis development. Cecal ligation and puncture model (CLP) was used to induce sepsis in the animals. The thymoquinone was given 1 hour before or after the CLP in the study groups with a dose of 500 mg·kg -1 . Erythrocyte deformability and relative resistance was calculated. Result: Relative resistance was increased in the sepsis groups when compared to the control group (p < 0.0001). Deformability index was increased in the sepsis group when compared to the other groups (p < 0.0001 in all groups). Sepsis group with after nigella sativa groups deformability index was significantly different from the deformability index in control group (p = 0.002). The use of nigella sativa before the initiation of sepsis corrected the deformability index significantly and the results were comparable to the control group (p = 0.078). Conclusion: Thymoquinone administration before induction of CLP was observed to have protective effects on these alterations in CLP sepsis (Tab. 1, Fig. 1, Ref. 26) . Text in PDF http://www.elis.sk/ .Keywords
This publication has 17 references indexed in Scilit:
- The protective effect of thymoquinone against sepsis syndrome morbidity and mortality in miceInternational Immunopharmacology, 2011
- Molecular biology of inflammation and sepsis: A primer*Critical Care Medicine, 2009
- Nigella sativa protects against ischaemia/reperfusion injury in rat kidneysNephrology Dialysis Transplantation, 2008
- Augmented erythrocyte band-3 phosphorylation in septic miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Suicidal erythrocyte death in sepsisJournal of Molecular Medicine, 2006
- Immunomodulatory and therapeutic properties of the Nigella sativa L. seedInternational Immunopharmacology, 2005
- Alterations of red blood cell shape and sialic acid membrane content in septic patientsCritical Care Medicine, 2003
- Oxidative stress and gene expression in sepsisBritish Journal of Anaesthesia, 2003
- Epidemiology of sepsis: An updateCritical Care Medicine, 2001
- Fixed Oil ofNigella sativaand Derived Thymoquinone Inhibit Eicosanoid Generation in Leukocytes and Membrane Lipid PeroxidationPlanta Medica, 1995